Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer

Inclusion Criteria: * Patients who tested positive EBV and confirmed suffering advanced nasopharyngeal cancer * Patients who have partial response or stable disease or progressive disease after performed standard therapy (radiology or chemoradiation) based on RECIST * Did not take traditional medicine in the last 2 months. * Patients can understand the nature of the study and willing to sign informed consent * Patients who received standard medical (radiology or chemoradiation) up to one additional therapy in the last 1 month. Exclusion Criteria: * Patients who are pregnant, planning to pregnant, or breastfeeding * Patients assessed to require chemoradiation during this study * Patients who get complete score after undergo standard therapy (radiology or chemoradiation) based on the RECIST * Patients who have autoimun reaction, eczema, allergy or allergy history, and anaphylaxis * Patients who have creatinin clearance result \<40 ml/min, bilirubin serum \>1.5x above normal, SGPT-SGOT \>5x above normal * Patients on immunosuppressive medications, such as corticosteroids * Patients who undergo Major thoracic or abdominal operation * Patients on high medical risk condition due to uncontrolled infection * Patients who diagnosed positive of Hepatitis B, Hepatitis C or Human Immunodeificiency virus (HIV) * Patients who have concurrent congestive heart failure history and other heart disease * Patients who have health conditions assessed by the doctor in charge cannot be included in this clinical trial * Patients who refuse or did not participate in part or all of the research process